ExploreWatchlistsPricing
  1. JP-listed companies
  2. NIPRO CORPORATION
  3. Financials
  4. Total assets

NIPRO CORPORATION (8086)

Market cap
¥283B
P/E ratio
20.8x
Nipro manufactures medical devices, generic pharmaceuticals, and pharma packaging materials, serving healthcare institutions with products like dialysis equipment, syringes, and glass vials.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndTotal assets (Million JPY)YoY (%)
Mar 31, 20251,170,564+5.47%
Mar 31, 20241,109,821+8.02%
Mar 31, 20231,027,399+10.43%
Mar 31, 2022930,321+8.89%
Mar 31, 2021854,396+2.71%
Mar 31, 2020831,865-1.65%
Mar 31, 2019845,821+2.31%
Mar 31, 2018826,759+9.82%
Mar 31, 2017752,839+6.20%
Mar 31, 2016708,882+1.95%
Mar 31, 2015695,306

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat